DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 38 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $12,087,787 | 66.30% |
| Samsara BioCapital, LLC | 801,629 | $3,086,272 | 0.54% |
| Orbimed Advisors | 4,945,192 | $19,038,989 | 0.34% |
| Alphabet Inc. | 1,636,258 | $6,299,593 | 0.34% |
| Newtyn Management, LLC | 200,000 | $770,000 | 0.18% |
| HARVARD MANAGEMENT CO INC | 326,029 | $1,255 | 0.12% |
| Acuitas Investments, LLC | 41,960 | $161,546 | 0.09% |
| Bronte Capital Management Pty Ltd. | 154,878 | $596,280 | 0.06% |
| UBS OCONNOR LLC | 199,200 | $766,920 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 25,000 | $96,250 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,100 | $458,535 | 0.01% |
| BESSEMER GROUP INC | 494,071 | $1,902 | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 10,113 | $38,935 | 0.00% |
| Point72 Asset Management, L.P. | 132,000 | $508,200 | 0.00% |
| BAILARD, INC. | 10,600 | $40,810 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 34,607 | $133,237 | 0.00% |
| Cubist Systematic Strategies, LLC | 10 | $39 | 0.00% |
| FEDERATED HERMES, INC. | 20,000 | $77,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 94 | $362 | 0.00% |
| NORTHERN TRUST CORP | 19,091 | $73,500 | 0.00% |
External links
This page lists DECIBEL THERAPEUTICS INC's shareholders in Q2 2023. To view DECIBEL THERAPEUTICS INC's shareholder history, click here.